Data Used In U.S. Trial Of AstraZeneca's COVID-19 Vaccine Questioned By Federal Health Agency
Results from a U.S. trial of AstraZeneca’s COVID-19 vaccine may have included “outdated information,” according to the National Institute of Allergy and Infectious Disease (NIAID).
Here & Now‘s Callum Borchers talks with Matthew Herper, senior writer for STAT, about the report.
This article was originally published on WBUR.org.
Copyright 2021 NPR. To see more, visit https://www.npr.org.